News | Cardiac Imaging | July 08, 2019

Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology

Leipsic to use $200,000 grant from annual SCCT award to further research on mechanisms of bioprosthetic valve failure

Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology

July 8, 2019 – Jonathon A. Leipsic, M.D., FSCCT, is the recipient of the 2019 DeHaan Award for Innovation in Cardiology, announced by the Society of Cardiovascular Computed Tomography (SCCT). Leipsic will present the second Dehaan Award Lecture at the SCCT 14th Annual Scientific Meeting, July 11-14 in Baltimore. The award, presented by the Jon DeHaan Foundation, includes a $200,000 grant.

Leipsic is the chairman of the department of radiology for Providence Health Care and the vice-chairman of research and a professor of radiology and cardiology for the University of British Columbia. He is a past president of the SCCT (2015-2016) and will also be awarded the SCCT Gold Medal Award in 2019.

Read the article "SCCT Announces 2019 Gold Medal Award Recipients"

“Dr. Leipsic has been a tireless champion, teacher and leader in cardiac applications of CT for many years. He has devoted countless hours toward advancing the field, and at the same time has thus touched many patients multiplied by the number of cardiologists who have used his work or who have learned from him directly.” said Robert Schwartz, M.D., chairman of the board for the Jon DeHaan Foundation. “It is a great pleasure that Dr. Leipsic has been chosen for the Jon H. DeHaan Foundation award for cardiovascular excellence in imaging, the purpose of which is to further his work and teaching, thus advancing cardiac CT far into the future.”

Leipsic intends to build on past work delving into the mechanisms of bioprosthetic valve failure. The data suggests that the mechanisms and timelines of valve degeneration are consistent across surgical and transcatheter bioprosthetic heart valves, and a better understanding of structural valve degeneration can be obtained through combining further histological and novel imaging approaches. Leipsic will continue along this path of investigation through the generous support of the DeHaan Foundation Award, which will allow him to perform the needed advanced analyses to help advance understanding of this complex process and potentially develop solutions to this important clinical problem.

The award lecture at the SCCT Annual Scientific Meeting, generously supported by the Jon Holden DeHaan Foundation, helps promote the knowledge and the use of cardiovascular CT to improve patient outcomes.

For more information:

Related Content

What to Look for in CT Structural Heart Planning Software

SCCT Releases New Guideline for CT Use During TAVR

Related Content

Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Example of an intentionally truncated CT image

Figure 1: Example of an intentionally truncated CT image. The truncation percentage was calculated as the ratio of the patient border touching the field of view to the total patient border (red/(read+blue)). Image courtesy of Qaelum.

Feature | Radiation Dose Management | July 15, 2019 | Niki Fitousi, Ph.D., and An Dedulle
One of the main benefits of a radiation dose management system is the possibility to automatically generate alerts when...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
Achenbach to Receive Inaugural 2019 Stephan Achenbach Pioneer Award in Cardiovascular CT
News | Cardiac Imaging | July 10, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present Stephan Achenbach, M.D., FSCCT with the inaugural...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...